Prevention and control of highly antibiotic-resistant bacteria in a Pacific territory: Feedback from New Caledonia between 2004 and 2020.

Carbapenem-resistant Enterobacteriaceae Multi-drug-resistant bacteria New Caledonia Outbreak Prevention Vancomycin-resistant Enterococcus

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 27 04 2021
revised: 11 07 2021
accepted: 27 08 2021
pubmed: 7 9 2021
medline: 2 2 2022
entrez: 6 9 2021
Statut: ppublish

Résumé

Carbapenemase-producing Enterobacteriaceae (CRE) and Enterococcus faecium resistant to vancomycin (VRE) constitute major threats to public health worldwide. The Pacific area is concerned and has implemented strategies to control antimicrobial resistance (AMR). However, accurate epidemiological data are rarely reported. Our study aimed to present the strategies applied to prevent and control the spread of highly resistant bacteria in the Pacific territory of New Caledonia. Cohort prospective study of all cases of highly resistant bacteria (HRB) isolated in New Caledonia from September 2004 to December 2020. Evaluation of the impact of the infection control measures implemented in healthcare settings: screening strategy, cohorting unit, IT tools and control of antibiotic prescriptions. A total of 346 patients with HRB were identified. Most of them (63.0%) were infected or colonized by VRE (n=218) and 128 by CRE. While the number of CREs significantly increased from 2013 to 2020 (P<0.0001), control procedures have limited their dissemination. Most patients were colonized by IMP-4-CRE (n=124/128). The incidence density of VRE significantly decreased from 38.52 for 100,000 hospitalisation-days in 2015 to 4.19 for 100,000 hospitalisation-days in 2019 due to systematic screening of patients before sanitary repatriation from Australia and cohorting implementation. The risk of VRE diffusion is now well under control. Our study confirms that it is possible to control the spread of AMR in a circumscribed territory by means of a global control strategy involving screening, cohorting unit, IT tools and antibiotic prescription controls.

Identifiants

pubmed: 34487876
pii: S2666-9919(21)00489-9
doi: 10.1016/j.idnow.2021.08.005
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-12

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

Julien Colot (J)

Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 98849 Nouméa, New Caledonia; Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia. Electronic address: Julien.colot@cht.nc.

Claire Fouquet (C)

Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Frédérique Ducrocq (F)

New Caledonian Health authorities, Direction des affaires sanitaires et sociales (DASS-NC), Nouméa, New Caledonia.

Sylvie Chevalier (S)

Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Christine Le Provost (C)

Infection control unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Cécile Cazorla (C)

Infectious diseases Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Camille Cheval (C)

Pharmacy Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Caroline Fijalkowski (C)

Pharmacy Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Ann-Claire Gourinat (AC)

Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 98849 Nouméa, New Caledonia.

Antoine Biron (A)

Microbiology Laboratory, Centre Hospitalier Territorial, Gaston Bourret, BP J5 98849 Nouméa, New Caledonia.

Cyrille Goarant (C)

Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia.

Alexandre Bourles (A)

Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia.

Benoît Marot (B)

Intensive Care Unit, Centre Hospitalier Territorial, Nouméa, New Caledonia.

Philippe Saliou (P)

Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia; Univ Brest, Inserm, EFS, UMR 1078, GGB, 29200 Brest, France; Infection control unit, CHU de Brest, 29200 Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH